ClinicalTrials.gg
Not yet recruitingNCT07934030Updated Nov 12, 2026

Breaks in Sedentary Behaviour and Executive Function

An interventional study of Uninterrupted sitting and Moderate-Intensity exercise in Sedentary Behavior / Physical Inactivity and Executive Function (Cognition), sponsored by Shenzhen University. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Shenzhen University · Not applicable, Interventional, and Basic science

How we know

Updated Nov 12, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 23 studies in Sedentary Behavior with a site in China — 10 open to participants now, 11 under way, none of them phase 3. Sedentary Behavior · China.

Planned enrollment
21st of 23
30 · median 75
Started
2026
with 8 others
No phase
23 of 23
10 open now
Primary completion
2027-02
later than 6 of 10 live
Registered
23rd of 23
by date

Among the 23 studies in Sedentary Behavior with a site in China, this one is the 21st largest by planned enrollment, is one of 9 that started in 2026, is one of 23 with no phase, reaches primary completion later than 6 of the 10 other live ones, and was the 23rd registered.

Sedentary Behavior

1,276 studies on the registry are indexed under Sedentary Behavior; 292 are open to participants now.

Browse Sedentary Behavior studies →

Open to participants now

10 of the 23 studies in Sedentary Behavior with a site in China are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 184 Sedentary Behavior studies recruiting now, 77 (42%) set no upper age limit and 82 (45%) stop at 75 or younger; 30 take children under 18; 97 take healthy volunteers.

This study: 18 Years to 30 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Sedentary Behavior with a site in China, or all of them as a file.
02

Study summary

This randomized controlled trial aims to investigate whether interrupting prolonged sitting with physical activity breaks can improve executive function in university students and to explore the potential underlying neural mechanisms. Participants will complete three experimental conditions in a randomized, within-subject crossover design: uninterrupted sitting (control condition), sitting interrupted by physical activity breaks, and a moderate-intensity exercise condition (exercise control). Executive function will be assessed before and after each condition using a computerized Stroop task. Functional near-infrared spectroscopy (fNIRS) will simultaneously monitor changes in cortical oxygenation, particularly in the prefrontal and parietal regions. The study hypothesizes that interrupting prolonged sitting with physical activity breaks will acutely improve executive function, particularly inhibitory control, compared with uninterrupted sitting. It is also expected that changes in cortical oxygenation may be associated with improvements in cognitive performance.

03

Conditions studied

  • Sedentary Behavior / Physical Inactivity
  • Executive Function (Cognition)

Browse trials for

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • right-handed (how was handedness assessed; i.e., "What hand do you write with?")
  • normal or corrected-to-normal vision and normal color vision

Exclusion criteria

Exclusion Criteria:

  • reported a history of cardiovascular, metabolic, gastrointestinal, neurological, or psychiatric disorders, cognitive impairment, medical conditions requiring medical care, substance addiction, strict diets (e.g., low- carbohydrate and Mediterranean diet), pregnancy, or lactation.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Uninterrupted sitting

    Participants will complete 100 minutes of uninterrupted sitting in a quiet room.

    Behavioral: Uninterrupted sitting

  • Experimental
    Sitting interrupted by physical activity breaks

    Participants will complete two 10-minute bouts of moderate-intensity cycling, each separated by 40 minutes of uninterrupted sitting.

    Behavioral: Uninterrupted sitting · Behavioral: Moderate-Intensity exercise

  • Experimental
    Preceding moderate-intensity exercise

    Participants will complete 20 minutes of moderate-intensity cycling followed by 80 minutes of uninterrupted sitting, serving as the exercise control condition.

    Behavioral: Uninterrupted sitting · Behavioral: Moderate-Intensity exercise

Interventions

  • BehavioralUninterrupted sitting

    Uninterrupted sitting in a quiet room.

  • BehavioralModerate-Intensity exercise

    Moderate-intensity cycling on Ergoline Ergoselect 100.

06

What researchers measure

Primary outcomes

  1. Cognitive function

    This primary outcome measure is assessed by the modified Stroop paradigm.

    Time frame: Immediately before and after each 100-minute experimental condition.

Secondary outcomes

  1. Change in Cortical Oxygenated Hemoglobin (Oxy-Hb)

    Functional near-infrared spectroscopy (fNIRS) will be used to assess changes in cortical oxygenated hemoglobin (Oxy-Hb) concentration, with a particular focus on the prefrontal and parietal regions.

    Time frame: During the Stroop task administered immediately before and after each 100-minute experimental condition.

  2. Brain Connectivity

    Brain connectivity is assessed by the functional near-infrared spectroscopy (fNIRS) .

    Time frame: During the Stroop task administered immediately before and after each 100-minute experimental condition.

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Feb 2027, 3 months later.

Of 736 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 30. This study's planned 3 months is below that.

Counting every sponsor, half of 744 studies reached it within 14 months; a quarter within 6 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 6, 2026
First posted
Nov 12, 2026
StartEst.
Nov 23, 2026
Primary completionEst.
Feb 23, 2027
CompletionEst.
Feb 28, 2027
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07934030
Lead sponsor
Shenzhen University
Responsible party
Liye Zou (Professor, Shenzhen University) — Principal investigator
First posted
Nov 12, 2026
Start date
Nov 23, 2026 (estimated)
Primary completion
Feb 23, 2027 (estimated)
Completion
Feb 28, 2027 (estimated)
Last update
Nov 12, 2026

Study contacts

Liye Zou
Contact
liyezou123@gmail.com
18823437684

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion